373110 — Xcell Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩41bn
- KR₩38bn
- KR₩2bn
Annual cashflow statement for Xcell Therapeutics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | — | -8,342 | -9,281 | -9,543 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 29.3 | 893 | 1,296 | 1,182 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -4,634 | -1,360 | -398 | -288 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -4,605 | -7,296 | -6,784 | -6,996 |
| Capital Expenditures | -1,396 | -1,324 | -234 | -820 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -263 | -142 | 55.1 | -452 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Change in Net Investments | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -1,659 | -1,466 | -179 | -1,272 |
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 14,232 | -439 | 2,763 | 14,790 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 7,971 | -9,196 | -4,197 | 7,761 |